Electrophysiological and behavioral effects of neurotensin in rat globus pallidus: An in vivo study

Experimental Neurology

Volumn 205, Issue 1, 2007, Pages 108-115

  Xue, Yan ^a   Chen, Lei ^a   Cui, Qiao Ling ^a   Xie, Jun Xia ^a   Yung, Wing Ho ^b  

^a QINGDAO UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Globus pallidus; Neurotensin; Single unit recording; SR142948A; SR48692

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; 2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; HALOPERIDOL; NEUROTENSIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DYSTONIA; ELECTROPHYSIOLOGY; GLOBUS PALLIDUS; IN VIVO STUDY; MALE; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DYSTONIA; ELECTROPHYSIOLOGY; GLOBUS PALLIDUS; HALOPERIDOL; INJECTIONS, INTRAPERITONEAL; MALE; MICROINJECTIONS; MOTOR ACTIVITY; NEURONS; NEUROTENSIN; OSMOLAR CONCENTRATION; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, NEUROTENSIN;

EID: 34247275313     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.01.031     Document Type: Article

References (49)

1. Alexander M.J., and Leeman S.E. Widespread expression in adult rat forebrain of mRNA encoding high-affinity neurotensin receptor. J. Comp. Neurol. 402 (1998) 475-500
2. Atoji Y., Watanabe H., Yamamoto Y., and Suzuki Y. Distribution of neurotensin-containing neurons in the central nervous system of the dog. J. Comp. Neurol. 353 (1995) 67-88
3. Augood S.J., Kiyama H., Faull R.L., and Emson P.C. Differential effects of acute dopaminergic D1 and D2 receptor antagonists on proneurotensin mRNA expression in rat striatum. Brain Res. Mol. Brain Res. 9 (1991) 341-346
4. Bergman H., Feingold A., Nini A., Raz A., Slovin H., Abeles M., and Vaadia E. Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci. 21 (1998) 32-38
5. Bissette G., Nemeroff C.B., Decker M.W., Kizer J.S., Agid Y., and Javoy-Agid F. Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease. Ann. Neurol. 17 (1985) 324-328
6. Boules M., Warrington L., Fauq A., McCormick D., and Richelson E. Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats. Eur. J. Pharmacol. 428 (2001) 227-233
7. Brauth S.E., Kitt C.A., Reiner A., and Quirion R. Neurotensin binding sites in the forebrain and midbrain of the pigeon. J. Comp. Neurol. 253 (1986) 358-373
8. Brog J.S., and Zahm D.S. Morphologically distinct subpopulations of neurotensin-immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus. Neuroscience 74 (1996) 805-812
9. Cadet J.L., Kujirai K., and Przedborski S. Bilateral modulation of [3H] neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: evidence from a receptor autoradiographic study. Brain Res. 564 (1991) 37-44
10. Carraway R., and Leeman S.E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248 (1973) 6854-6861
11. Chan C.S., Surmeier D.J., and Yung W.H. Striatal information signaling and integration in globus pallidus: timing matters. NeuroSignals 14 (2005) 281-289
12. Chen L., Yung K.K.L., and Yung W.H. Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor. Neuroscience 125 (2004) 853-859
13. Chen X., Ge Y.L., Jiang Z.Y., Liu C.Q., Depoortere I., and Peeters T.L. Effects of ghrelin on hypothalamic glucose responding neurons in rats. Brain Res. 1055 (2005) 131-136
14. Chinaglia G., Probst A., and Palacios J.M. Neurotensin receptors in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study in basal ganglia. Neuroscience 39 (1990) 351-360
15. DeLong M.R. Activity of pallidal neurons during movement. J. Neurol. 34 (1971) 414-427
16. El-Deredy W., Branston N.M., Samuel M., Schrag A., Rothwell J.C., Thomas D.G., and Quinn N.P. Firing patterns of pallidal cells in parkinsonian patients correlate with their pre-pallidotomy clinical scores. NeuroReport 11 (2000) 3413-3418
17. Fassio A., Evans G., Grisshammer R., Bolam J.P., Mimmack M., and Emson P.C. Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody. Neuropharmacology 39 (2000) 1142-1430
18. Fernandez A., de Ceballos M.L., Jenner P., and Marsden C.D. Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients. Neuroscience 61 (1994) 73-79
19. Fernandez A., Jenner P., Marsden C.D., and De Ceballos M.L. Characterization of neurotensin-like immunoreactivity in human basal ganglia: increased neurotensin levels in substantia nigra in Parkinson's disease. Peptides 16 (1995) 339-346
20. Ferraro L., Tomasini M.C., Siniscalchi A., Fuxe K., Tanganelli S., and Antonelli T. Neurotensin increases endogenous glutamate release in rat cortical slices. Life Sci. 66 (2000) 927-936
21. Garver D.L., Bissette G., Yao J.K., and Nemeroff C.B. Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients. Am. J. Psychiatry 148 (1991) 484-488
22. Hebb M.O., and Robertson H.A. Synergistic influences of the striatum and the globus pallidus on postural and locomotor control. Neuroscience 90 (1999) 413-421
23. Hokfelt T., Broberger C., Xu Z.Q.D., Sergeyev V., Ubink R., and Diez M. Neuropeptides: an overview. Neuropharmacology 39 (2000) 1337-1356
24. Holtom P.E., Needham P.L., Bennett G.W., and Aspley S. Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions. Br. J. Pharmacol. 131 (2000) 990-996
25. Kasckow J., and Nemeroff C.B. The neurobiology of neurotensin: focus on neurotensin-dopamine interactions. Regul. Pept. 36 (1991) 153-164
26. Kelland M.D., Soltis R.P., Anderson L.A., Bergstrom D.A., and Walters J.R. In vivo characterization of two cell types in the rat globus pallidus which have opposite responses to dopamine receptor stimulation: comparison of electrophysiological properties and responses to apomorphine, dizocilpine, and ketamine anesthesia. Synapse 20 (1995) 338-350
27. Kinkead B., and Nemeroff C.B. Neurotensin, schizophrenia, and antipsychotic drug action. Int. Rev. Neurobiol. 59 (2004) 327-349
28. Le F., Cusack B., and Richelson E. The neurotensin receptor: is there more than one subtype?. Trends Pharmacol. Sci. 17 (1996) 1-3
29. Lozano A., Hutchison S., Kiss Z., Tasker R., Davis K., and Dostromxky J. Methods for microelectrode-guided posteroventral pallidotomy. J. Neurosurg. 84 (1996) 194-202
30. Martorana A., Fusco F.R., D'Angelo V., Sancesario G., and Bernardi G. Enkephalin, neurotensin, and substance P immunoreactive neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra. Exp. Neurol. 183 (2003) 311-319
31. Martorana A., Martella G., D'Angelo V., Fusco F.R., Spadoni F., Bernardi G., and Stefani A. Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. Synapse 60 (2006) 371-383
32. Matsumura M., Tremblay L., Richard H., and Filion M. Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum. Neuroscience 65 (1995) 59-70
33. McCormick S.E., and Stoessl A.J. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia. Neuroscience 119 (2003) 547-555
34. Merchant K.M., and Dorsa D.M. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 3447-3451
35. Merchant K.M., Bush L.G., Gibb J.W., and Hanson G.R. Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain. Brain Res. 500 (1989) 21-29
36. Miwa H., Nishi K., Fuwa T., and Mizuno Y. Effects of blockade of metabotropic glutamate receptors in the subthalamic nucleus on haloperidol-induced Parkinsonism in rats. Neurosci. Lett. 282 (2000) 21-24
37. Morin A.J., Tajani M., Jones B.E., and Beaudet A. Spatial relationship between neurotensinergic axons and cholinergic neurons in the rat basal forebrain: a light microscopic study with three-dimensional reconstruction. J. Chem. Neuroanat. 10 (1996) 147-156
38. Nicot A., Rostene W., and Berod A. Neurotensin receptor expression in the rat forebrain and midbrain: a combined analysis by in situ hybridization and receptor autoradiography. J. Comp. Neurol. 341 (1994) 407-419
39. Palacios J.M., and Kuhar M.J. Neurotensin receptors are located on dopamine-containing neurones in rat midbrain. Nature 294 (1981) 587-589
40. Palacios J.M., Chinaglia G., Rigo M., Ulrich J., and Probst A. Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia. Synapse 7 (1991) 114-122
41. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
42. Pycock C. Turning behavior in animal. Neuroscience 5 (1980) 461-514
43. Querejeta E., Oviedo-Chavez A., Araujo-Alvarez J.M., Quinones-Cardenas A.R., and Delgado A. In vivo effects of local activation and blockade of 5-HT1B receptors on globus pallidus neuronal spiking. Brain Res. 1043 (2005) 186-194
44. Ruskin D.N., Rawji S.S., and Walters J.R. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393. J. Pharmacol. Exp. Ther. 286 (1998) 272-281
45. Sarret P., Krzywkowski P., Segal L., Nielsen M.S., Petersen C.M., Mazella J., Stroh T., and Beaudet A. Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system. J. Comp. Neurol. 461 (2003) 483-505
46. Sarret P., Perron A., Stroh T., and Beaudet A. Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system. J. Comp. Neurol. 461 (2003) 520-538
47. Seethalakshmi L., Mitra S.P., Dobner P.R., Menon M., and Carraway R.E. Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate 31 (1997) 183-192
48. Zahm D.S. Subsets of neurotensin-immunoreactive neurons revealed following antagonism of the dopamine-mediated suppression of neurotensin immunoreactivity in the rat striatum. Neuroscience 46 (1992) 335-350
49. Zahm D.S., and Heimer L. Ventral striatopallidal parts of the basal ganglia in the rat: I. Neurochemical compartmentation as reflected by the distributions of neurotensin and substance P immunoreactivity. J. Comp. Neurol. 272 (1988) 516-535